Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Akoya Biosciences Inc (AKYA)
Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Akoya Biosciences Inc 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 USA

www.akoyabio.com P: 855-896-8401

Description:

Akoya Biosciences Inc. offers comprehensive single-cell imaging solutions which allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. The company offer distinct solutions, the CODEX(R) and Phenoptics(TM) platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. Akoya Biosciences Inc. is based in MARLBOROUGH, Mass.

Key Statistics

Overview:

Market Capitalization, $K 231,639
Enterprise Value, $K 220,689
Shares Outstanding, K 49,076
Annual Sales, $ 74,860 K
Annual Net Income, $ -70,640 K
Last Quarter Sales, $ 25,220 K
Last Quarter Net Income, $ -12,920 K
EBIT, $ -57,880 K
EBITDA, $ -50,730 K
60-Month Beta 1.43
% of Insider Shareholders 8.50%
% of Institutional Shareholders 39.46%
Float, K 44,905
% Float 91.50%
Short Volume Ratio 0.36

Growth:

1-Year Return -64.78%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.26 on 11/08/23
Next Earnings Date N/A
Earnings Per Share ttm -1.76
EPS Growth vs. Prev Qtr 49.02%
EPS Growth vs. Prev Year 44.68%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AKYA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -121.74%
Return-on-Assets % -41.01%
Profit Margin % -94.36%
Net Margin % N/A
Debt/Equity 0.90
Price/Sales 2.88
Price/Cash Flow N/A
Price/Book 3.47
Book Value/Share 1.27
Interest Coverage -14.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar